Anticorps Recombinant de lapin anti-MMP9
MMP9 Recombinant Antibody for FC (Intra)
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
FC (Intra)
Conjugaison
Non conjugué
CloneNo.
230069F1
N° de cat : 98396-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en FC (Intra) | cellules RAW 264.7 traitées au LPS et à la bréfeldine A, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98396-1-RR cible MMP9 dans les applications de FC (Intra) et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | MMP9 Protéine recombinante Eg0452 |
| Nom complet | matrix metallopeptidase 9 |
| Masse moléculaire calculée | 81kd |
| Numéro d’acquisition GenBank | NM_013599 |
| Symbole du gène | Mmp9 |
| Identification du gène (NCBI) | 17395 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
MMP9 (matrix metallopeptidase 9), also named as Gelatinase B, is a member of matrix metalloproteinase (MMP) family. The MMP family of enzymes is comprised of critically important extracellular matrix remodeling proteases whose activity has been implicated in normal embryogenesis, tissue remodelling and many diseases such as arthritis, cancer, periodontitis, glomerulonephritis, encephalomyelitis, atherosclerosis and tissue ulceration. MMP9 is produced by a variety of normal and transformed cells including neutrophils, monocytes, macrophages, astrocytes, fbroblasts, osteoclasts and so on. Transgenic mouse models report that MMP9 contributes to skin carcinogenesis, suppresses development of experimental abdominal aortic aneurysms, and triggers the angiogenic switch during carcinogenesis.
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for MMP9 antibody 98396-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |


